Guardian Capital Advisors LP Novartis Ag Transaction History

Guardian Capital Advisors LP

  • $878 Million
  • Q2 2024

A detailed history of Guardian Capital Advisors LP transactions in Novartis Ag stock. As of the latest transaction made, Guardian Capital Advisors LP holds 2,175 shares of NVS stock, worth $240,468. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,175
Previous 43,898 95.05%
Holding current value
$240,468
Previous $4.25 Million 94.56%
% of portfolio
0.03%
Previous 0.46%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $3.86 Million - $4.48 Million
-41,723 Reduced 95.05%
2,175 $231,000
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $61,258 - $69,746
-643 Reduced 1.44%
43,898 $4.25 Million
Q4 2023

Feb 08, 2024
BUY
$92.27 - $101.54 $12,179 - $13,403
132 Added 0.3%
44,541 $4.5 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $17,051 - $18,923
180 Added 0.41%
44,409 $4.52 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $150,252 - $170,373
-1,624 Reduced 3.54%
44,229 $4.46 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $4,401 - $5,104
-55 Reduced 0.12%
45,853 $4.22 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $44,196 - $54,124
-585 Reduced 1.26%
45,908 $4.16 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $35,439 - $41,448
-475 Reduced 1.01%
46,493 $3.5 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $47,909 - $55,781
-595 Reduced 1.25%
46,968 $3.88 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $336,462 - $380,604
4,200 Added 9.69%
47,563 $4.41 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $289,311 - $319,911
-3,630 Reduced 7.72%
43,363 $3.89 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $15,129 - $17,600
185 Added 0.4%
46,993 $3.88 Million
Q2 2021

Aug 17, 2021
BUY
$85.24 - $94.15 $54,127 - $59,785
635 Added 1.38%
46,808 $4.31 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $76,820 - $90,592
920 Added 2.03%
46,173 $4.01 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $53,477 - $64,684
685 Added 1.54%
45,253 $4.28 Million
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $4,517 - $5,005
55 Added 0.12%
44,568 $3.9 Million
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $31,562 - $35,529
390 Added 0.88%
44,513 $2.81 Million
Q1 2020

May 15, 2020
SELL
$70.67 - $99.01 $11,660 - $16,336
-165 Reduced 0.37%
44,123 $2.51 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $24,461 - $27,657
290 Added 0.66%
44,288 $4.18 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $41,059 - $45,244
480 Added 1.1%
43,998 $3.71 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $16,965 - $20,880
225 Added 0.52%
43,518 $4.03 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $25,608 - $29,291
340 Added 0.79%
43,293 $3.31 Million
Q4 2018

Feb 13, 2019
BUY
$73.66 - $82.02 $25,412 - $28,296
345 Added 0.81%
42,953 $3.73 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $60,246 - $69,687
-900 Reduced 2.07%
42,608 $3.63 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $76,593 - $86,564
1,180 Added 2.79%
43,508 $3.42 Million
Q1 2018

May 15, 2018
BUY
$70.39 - $84.15 $41,882 - $50,069
595 Added 1.43%
42,328 $3.43 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $96,198 - $103,261
1,330 Added 3.29%
41,733 $3.63 Million
Q3 2017

Nov 15, 2017
BUY
$74.14 - $77.27 $115,287 - $120,154
1,555 Added 4.0%
40,403 $3.46 Million
Q2 2017

Aug 14, 2017
BUY
N/A
38,848
38,848 $3.21 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Guardian Capital Advisors LP Portfolio

Follow Guardian Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email